Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19 a UK-wide cross-sectional surveillance study



Russell, Amy L Ross, Hardwick, Marc, Jeyanantham, Athavan, White, Laura M, Deb, Saumitro, Burnside, Girvan ORCID: 0000-0001-7398-1346, Joy, Harriet M, Smith, Craig J, Pollak, Thomas A, Nicholson, Timothy R
et al (show 30 more authors) (2021) Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19 a UK-wide cross-sectional surveillance study. BRAIN COMMUNICATIONS, 3 (3). fcab168-.

[img] Text
Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19 a UK-wide cross-sectional surv.pdf - Published version

Download (1MB) | Preview

Abstract

SARS-CoV-2 is associated with new-onset neurological and psychiatric conditions. Detailed clinical data, including factors associated with recovery, are lacking, hampering prediction modelling and targeted therapeutic interventions. In a UK-wide cross-sectional surveillance study of adult hospitalized patients during the first COVID-19 wave, with multi-professional input from general and sub-specialty neurologists, psychiatrists, stroke physicians, and intensivists, we captured detailed data on demographics, risk factors, pre-COVID-19 Rockwood frailty score, comorbidities, neurological presentation and outcome. <i>A priori</i> clinical case definitions were used, with cross-specialty independent adjudication for discrepant cases. Multivariable logistic regression was performed using demographic and clinical variables, to determine the factors associated with outcome. A total of 267 cases were included. Cerebrovascular events were most frequently reported (131, 49%), followed by other central disorders (95, 36%) including delirium (28, 11%), central inflammatory (25, 9%), psychiatric (25, 9%), and other encephalopathies (17, 7%), including a severe encephalopathy (<i>n</i> = 13) not meeting delirium criteria; and peripheral nerve disorders (41, 15%). Those with the severe encephalopathy, in comparison to delirium, were younger, had higher rates of admission to intensive care and a longer duration of ventilation. Compared to normative data during the equivalent time period prior to the pandemic, cases of stroke in association with COVID-19 were younger and had a greater number of conventional, modifiable cerebrovascular risk factors. Twenty-seven per cent of strokes occurred in patients <60 years. Relative to those >60 years old, the younger stroke patients presented with delayed onset from respiratory symptoms, higher rates of multi-vessel occlusion (31%) and systemic thrombotic events. Clinical outcomes varied between disease groups, with cerebrovascular disease conferring the worst prognosis, but this effect was less marked than the pre-morbid factors of older age and a higher pre-COVID-19 frailty score, and a high admission white cell count, which were independently associated with a poor outcome. In summary, this study describes the spectrum of neurological and psychiatric conditions associated with COVID-19. In addition, we identify a severe COVID-19 encephalopathy atypical for delirium, and a phenotype of COVID-19 associated stroke in younger adults with a tendency for multiple infarcts and systemic thromboses. These clinical data will be useful to inform mechanistic studies and stratification of patients in clinical trials.

Item Type: Article
Uncontrolled Keywords: COVID-19, SARS-CoV-2, encephalopathy, stroke, neurology
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Infection, Veterinary and Ecological Sciences
Depositing User: Symplectic Admin
Date Deposited: 01 Feb 2022 15:53
Last Modified: 18 Jan 2023 21:14
DOI: 10.1093/braincomms/fcab168
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3147967